Cambridge Investment Research Advisors
LOXO

Cambridge Investment Research Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,675
Closed -$375K – 2388
2018
Q4 		$375K Sell
2,675
-100
-4% -$15.2K ﹤0.01% 1500
2018
Q3 		$474K Buy
2,775
+315
+13% +$52.9K ﹤0.01% 1476
2018
Q2 		$427K Buy
2,460
+100
+4% +$15K ﹤0.01% 1490
2018
Q1 		$272K Sell
2,360
-557
-19% -$59.2K ﹤0.01% 1743
2017
Q4 		$246K Buy
2,917
+617
+27% +$51.4K ﹤0.01% 1782
2017
Q3 		$212K Buy
+2,300
New +$179K ﹤0.01% 1788

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Cambridge Investment Research Advisors's LOXO Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,675 shares — an estimated $375K sold.

Cambridge Investment Research Advisors first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $474K in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Cambridge Investment Research Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,675 Loxo Oncology, Inc shares in Q1 2019, an estimated $375K.
  • Cambridge Investment Research Advisors first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's Loxo Oncology, Inc position peaked at $474K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.